With stocks at all-time highs, this dividend stock is more expensive than before. But with solid financials, an above-average yield and one of the longest… Read More »This Dividend Stock Has Plenty Of Appeal Despite Its Price
Whatever may be in store for the market, investors can’t go wrong by picking up blue-chip stocks that pay solid dividends. Here are three in… Read More »3 Appetizing Blue Chips With Solid Dividends
When it comes to trading options, the straddle and the strangle are both profitable strategies – but each is best-suited for particular situations. CLICK HERE.
Goldman Sachs is especially bullish on the direction of the stock market this year – and sees a particular untapped opportunity in these 21 consumer… Read More »Untapped Opportunity In These Consumer Cyclicals
For investors interested in stocks on the way down, these two names are looking technically bearish – and could present interesting short opportunities. CLICK HERE.
While some utility stocks have had to slash their dividends during the pandemic, there are plenty that have continued to boost their payouts. Here are… Read More »Attractive Dividends In An Unloved Sector
Analyst upgrades can help drive stock prices higher – and of all the stocks in the S&P 500, these 22 have seen the biggest increases… Read More »The 22 Stocks With The Most New “Buy” Ratings
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
While owning individual preferred stocks provides more stability, for a “packaged” preferred stock product, consider this actively managed ETF with an attractive 8.6% yield. CLICK… Read More »A Packaged Preferred Stock Product With An Attractive Yield
Radiation, surgery, chemotherapy…and electric fields? This oncology company has developed a fourth paradigm for treating cancer – and has multiple data readouts this year that… Read More »A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year